Lu Y Y, Cai J J, Jin S W, Wang C H, Zhou Y F, Hu M P, Li J
Department of Anesthesiology and Perioperative Medicine, the Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325027, China.
Zhonghua Yi Xue Za Zhi. 2020 Feb 11;100(5):363-366. doi: 10.3760/cma.j.issn.0376-2491.2020.05.009.
To investigate the effects of dural puncture epidural technique for labor analgesia on mothers and neonates. From January to June 2019, one hundred healthy and nulliparous women, scheduled for elective labor analgesia in the Second Affiliated Hospital of Wenzhou Medical University, met inclusion criteriaand were recruitedin this prospective study. The inclusion criteria are as follows: American Society of Anesthesiologists physical statusⅠorⅡ, New York Heart Association gradeⅠorⅡ,150-175 cm in height,50-90 kg in weight and 37-45 weeks of gestation. They were randomly divided into epidural analgesia group(group P, 50)and dural puncture epidural group(group D, 50) by using random number table. Parturients in group D received epidural catheterization immediate after successful epidural puncture, while parturients in group P received a single dural puncture into subarachnoid space with a 27 gauge needle (successful puncture: outflow of cerebrospinal fluid) before epidural catheterization. Epidural labor analgesia was performed with epidural infusion of 0.1% ropivacaine plus 0.25 μg/ml sufentanil in both groups. The VAS scores were evaluated at the following time points: before epidural infusion, each uterine contraction within 30 min after infusion, 30 min, 60 min and 90 min after infusion and withdrawal of infusion. Labor process, mode of delivery, cases of increased oxytocin using, effective PCA pressings, sufentanil and ropivacaine dosages, complications of analgesia, neonatal status were recorded, as well. There were no significant differences in labor duration, mode of delivery, analgesia complications (nausea and vomiting, itching, headache after delivery and Bromage score for motor block), deceleration of fetal heart rate and neonatal Apgar score between the two groups (0.05). The number of effective PCA pressings, sufentanil dosage, ropivacaine dosage and cases of increased using of oxytocin were significantly more in group P(8.663,7.024,6.509,χ(2)=4.159,all 0.05), with (8.6±2.5) times, (29±4) μg,(105±15) mg,28% in group P, compared with (4.6±2.1) times,(23±4) μg,(88±12) mg,10% in group D, respectively. The first four VAS scores of uterine contraction after analgesia in group P(VAS=7.9±1.1,6.8± 0.9, 5.6±0.8, 4.5±0.8)were significantly higher than those in group D (VAS=6.8±0.7,4.7±0.8,3.5±0.8,2.9±0.7,5.966,12.332,13.125,10.643,all 0.05). The VAS scores at 90 min after analgesia and withdrawal of analgesia (VAS=2.7±0.6, 2.9±0.7) in group P were significantly higher than those in group D (VAS=2.4±0.6, 2.5±0.6, 2.500, 3.068, all 0.05). Compared with traditional epidural technique, dural puncture epidural technique can provide a rapid and effective analgesia with less analgesics, but without increasing adverse effects on mother and infant.
探讨硬膜外穿刺硬膜外技术用于分娩镇痛对母婴的影响。2019年1月至6月,温州医科大学附属第二医院100例计划择期分娩镇痛的健康初产妇符合纳入标准,被纳入本前瞻性研究。纳入标准如下:美国麻醉医师协会身体状况Ⅰ或Ⅱ级,纽约心脏协会分级Ⅰ或Ⅱ级,身高150 - 175 cm,体重50 - 90 kg,孕周37 - 45周。采用随机数字表法将其随机分为硬膜外镇痛组(P组,50例)和硬膜穿刺硬膜外组(D组,50例)。D组产妇在硬膜外穿刺成功后立即行硬膜外导管置入,而P组产妇在硬膜外导管置入前行蛛网膜下腔单次硬膜穿刺,使用27号穿刺针(穿刺成功:有脑脊液流出)。两组均采用硬膜外输注0.1%罗哌卡因加0.25μg/ml舒芬太尼进行分娩镇痛。在以下时间点评估视觉模拟评分(VAS):硬膜外输注前、输注后30 min内每次宫缩时、输注后30 min、60 min和90 min以及停止输注时。记录产程、分娩方式、缩宫素增加使用例数、有效自控镇痛按压次数、舒芬太尼和罗哌卡因用量、镇痛并发症、新生儿情况。两组在产程、分娩方式、镇痛并发症(恶心呕吐、瘙痒、产后头痛及运动阻滞Bromage评分)、胎儿心率减速及新生儿阿氏评分方面无显著差异(P>0.05)。P组有效自控镇痛按压次数、舒芬太尼用量、罗哌卡因用量及缩宫素增加使用例数均显著多于D组(分别为8.663、7.024、6.509,χ² = 4.159,均P<0.05),P组分别为(8.6±2.5)次、(29±4)μg、(105±15)mg、28%,D组分别为(4.6±2.1)次、(23±4)μg、(88±12)mg、10%。P组镇痛后宫缩的前四个VAS评分(VAS = 7.9±1.1、6.8±0.9、5.6±0.8、4.5±0.8)显著高于D组(VAS = 6.8±0.7、4.7±0.8、3.5±0.8、2.9±0.7,F = 5.966、12.332、13.125、10.643,均P<0.05)。P组镇痛后90 min及停止镇痛时的VAS评分(VAS = 2.7±0.6、2.9±0.7)显著高于D组(VAS = 2.4±0.6、2.5±0.6,F = 2.500、3.068,均P<0.05)。与传统硬膜外技术相比,硬膜穿刺硬膜外技术能以较少的镇痛药提供快速有效的镇痛,且不增加对母婴的不良影响。